Newsroom

Welcome to the DermaSensor Newsroom. Here, you'll find the latest articles from skin-evaluation experts, discover emerging technology entering the market, and learn how general practitioners are adopting faster, easier, smarter tools to improve clinical decision making for their patients. See what the future standard of skin evaluation looks like, from Melbourne to Miami.

[custom-facebook-feed feed=1]

DermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients

Presented at the 2023 American Academy of Dermatology Innovation Academy, the findings demonstrate the potential for DermaSensor’s device to help detect skin cancer across a range of skin types MIAMI, August 10, 2023, Business Wire …

DermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients Read More »

DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting

DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and Older MIAMI, July 13, 2023, Business Wire — DermaSensor Inc., a health technology company equipping primary care physicians …

DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting Read More »

DermaSensor Kicks off Skin Cancer Awareness Month by Winning “Best New Technology Solution in Dermatology”

MIAMI, May 9, 2023, EINPresswire.com — DermaSensor Inc. is pleased to announce that it is a winner in the 2023 MedTech Breakthrough Awards program for its innovative, non-invasive device that better equips primary care physicians …

DermaSensor Kicks off Skin Cancer Awareness Month by Winning “Best New Technology Solution in Dermatology” Read More »

DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs

Presented at the Society of Teachers of Family Medicine (STFM) 2023 annual meeting, the two FDA pivotal studies validated the performance and benefit of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation. …

DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs Read More »

Scroll to Top